Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
44.34 USD | +1.66% | +3.91% | -1.18% |
10:36am | Qiagen Receives FDA Clearance for Clinical Use of Respiratory Infection Test | MT |
08:55am | Qiagen Obtains US FDA Clearance for Respiratory Syndromic Testing Panel | MT |
Financials (USD)
Sales 2024 * | 2.01B | Sales 2025 * | 2.14B | Capitalization | 9.67B |
---|---|---|---|---|---|
Net income 2024 * | 404M | Net income 2025 * | 450M | EV / Sales 2024 * | 4.98 x |
Net Debt 2024 * | 325M | Net cash position 2025 * | 206M | EV / Sales 2025 * | 4.43 x |
P/E ratio 2024 * |
23.9
x | P/E ratio 2025 * |
21.5
x | Employees | 5,900 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.67% |
Latest transcript on Qiagen N.V.
1 day | +1.05% | ||
1 week | +3.41% | ||
Current month | +4.02% | ||
1 month | +10.99% | ||
3 months | +2.73% | ||
6 months | +11.34% | ||
Current year | -1.66% |
Managers | Title | Age | Since |
---|---|---|---|
Thierry Bernard
CEO | Chief Executive Officer | 60 | 15-01-31 |
Metin Colpan
FOU | Founder | 69 | 96-04-28 |
Roland Sackers
DFI | Director of Finance/CFO | 56 | 98-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 74 | 11-05-31 | |
Metin Colpan
FOU | Founder | 69 | 96-04-28 |
Lawrence Rosen
CHM | Chairman | 66 | 13-06-25 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
3.10% | 1 M€ | -2.17% | - | |
1.79% | 2 M€ | -.--% | ||
1.65% | 2 M€ | +9.27% | ||
1.32% | 144 M€ | +2.21% | ||
1.08% | 8 M€ | +4.88% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-13 | 44.25 | +1.47% | 407 157 |
24-05-10 | 43.61 | +0.07% | 655,246 |
24-05-09 | 43.58 | +1.49% | 675,307 |
24-05-08 | 42.94 | -0.02% | 1,097,280 |
24-05-07 | 42.95 | +0.87% | 840,965 |
Delayed Quote Nyse, May 13, 2024 at 12:37 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.66% | 9.67B | |
+23.93% | 44.96B | |
+0.40% | 42.65B | |
+46.00% | 41.85B | |
-5.31% | 29.04B | |
+10.80% | 26.08B | |
-21.14% | 19.03B | |
+6.86% | 12.75B | |
+29.27% | 12.06B | |
-3.40% | 11.75B |
- Stock Market
- Equities
- QGEN Stock